SYNLAB AG (DB:SYAB) agreed to acquire Laboratorio Médico Polanco and Laboratorio Clinicos de Puebla from Médica Sur, S.A.B. de C.V. (BMV:MEDICA B) on August 2, 2021. In 2020, LMP & LCR achieved revenues of MXN 1.3 billion, including COVID-19 testing services. With the scheduled acquisition, SYNLAB will incorporate LMP & LCR's dense network of more than 100 diagnostic service points mainly located around Mexico City and Puebla and employing 1,700 people.

The acquisition is subject to customary anti-trust approvals, with closing expected in Q4 2021. Galicia Abogados, S.C acted as legal advisor for SYNLAB AG. Banco Santander, S.A. (BME:SAN) acted as financial adviosr to Laboratorio Médico Polanco, S.A. De C.V./Laboratorio Clinicos de Puebla.